4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0000921895-17-000024
Director bought 40 shares at $6.51 ($260)
- Director acquired 363,611 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eberwein Jeffrey E. Director | 2016-12-30 | Purchase | +40 | $6.51 | $260 | 69,911 | I: show line 1 in the form |
| Eberwein Jeffrey E. Director | 2016-12-30 | Other acquisition | +363,611 | $50.00 | $18,180,550 | 363,611 | I: show line 2 in the form |
| Open-market purchases · 40 sh · avg $6.51 · $260 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eberwein Jeffrey E. Director | 2016-12-30 | Other disposition · 5% Convertible Note due May 2017 | −0 | $5,000,000.00 | $0 | 0 | I: show line 3 in the form |
Loading xslF345X03/form410211002_01042017.xml…